期刊文献+

氯沙坦/双氢氯塞嗪治疗原发性高血压40例的疗效观察 被引量:2

Evaluation of treatment efficacy with losartan and hydrochlorothiazide in patients with essential hypertension
下载PDF
导出
摘要 目的 评价联合应用氯沙坦 5 0mg/d和双氢氯塞嗪 12 .5mg/d治疗原发性高血压的疗效。方法 选择高血压病患者(其中 1级 15例、2级 15例、3级 10例 ) ,应用氯沙坦 5 0mg/d和双氢氯塞嗪 12 .5mg/d治疗 ,每日监测血压 ,并以第四周末血压为最后结果 ,同时观察HR、干咳发生率和临床实验检查结果。结果 该方法对高血压患者治疗有效率和显效率分别为 :1级组 93%和 80 % ,2级组 93%和 73% ,3级组 6 0 %和 30 %。对HR和临床实验检查结果无明显影响。结论 联合应用氯沙坦和双氢氯塞嗪治疗高血压病 1级和 2级的疗效确切 ,对 3级高血压需联合用药 ,其副作用小。 Objective To evaluate the efficacy treatment with losartan (50mg/d) and hydrochlorothiazide (12.5mg/d) in patients with essential hypertension.Methods Patients with essential hypertension were selected (1st grade group with 15 patients and 2nd grade group with15 ?3rd grade group with 10) and treated with losartan (50mg/d) and hydrochlorothiazide (12.5mg/d). After 4 weeks treatment, the blood pressure was measured?and heart rate?the incidence of dry cough and clinical laboratory measurements was assessed. Results The efficiency rate and obvious efficiency rate were: 1st grade group (93% and 80% ), 2nd grade group (93% and 73%),3rd grade group (60% and 30%). There were no significant difference in clinical laboratory measurements. Conclusion It was effective in the treatment with losartan (50mg/d) and hydrochlorothiazide (12.5mg/d) in patients with 1st and 2nd grade essential hypertension, but it should combinate of the other drugs in the 3rd grade essential hypertension
出处 《重庆医学》 CAS CSCD 2002年第9期810-811,共2页 Chongqing medicine
关键词 氯沙坦 双氢氯塞嗪 治疗 原发性高血压 疗效观察 hypertension angiotensin Ⅱreceptor antagonist losartan hydrochlorothiazide
  • 相关文献

参考文献10

  • 1Haralambos Gavras. The cardiovascular continnum: The rationale for Ang Ⅱ antagonism[M]. Asia Pacific Losar tan Symposium. Hong Kong, 1999.20.
  • 2朱妙章,臧益民,贾敏江,肖优芳.心肌缺血预适应及其机制[J].心功能杂志,1999,11(4):263-265. 被引量:17
  • 3黎龙琼,李隆贵.盐与高血压的新进展[J].重庆医学,2001,30(1):77-78. 被引量:13
  • 4Timmermans PB, Wong PC, Chiu AT, et al. Angioten sin Ⅱ receptors and Angiotensin Ⅱ receptor antagonists [J]. Pharmacol Rev,1993,45(1) :205.
  • 5Kirk JK. Angiotensin Ⅱ receptor antagonists, their place in therapy[J]. Am Fam Physician,1999,59(11): 314.
  • 6Dahlof B,Keller SE, Makrisl L, et al. Efficacy and toler ability of Losartan potassium and antenolol in patient with mild to moderate essential hypertension[J]. Am J Hyper tens, 1995,8(6): 578.
  • 7Roca-Cusachs A, Oigman W, Lepe L, et al. A randomized double-blind comparison of the antihypertensive effi cacy and safety of once-daily. Losartan compared totwice-daily captopril in mild to moderate essential hypertension[J]. Acta Cardiol, 1997,52(6) : 495.
  • 8Tikkanen Ⅰ, Omvik P, Jensen HA. Comparison of the angiotensin Ⅱ antagonist losartan with the angiotrnsin converting enzyme inhibitor enalapril in patients with essential hypertension[J]. J Hypertens, 1995, 13(11):1343.
  • 9薛玉生,郑强荪,张利华,杨欣国,柳荫.氯沙坦治疗轻、中度高血压病疗效的评价[J].心脏杂志,2000,12(4):257-259. 被引量:6
  • 10Bryan Williams. Blood pressure. Reduction-strategies to Achieve goal [M]. Asia Pacific Losartan Symposium.Hong Kong, 1999.20.

二级参考文献16

  • 1[1]Hamet,pausova Z,Adarichev V,et al.Hypertension:genes and environment[J].J Hypertension,1998,16:397.
  • 2[2]Hatton DC,Mccarron DA.Dietary salt and hypertension[J].Nephroloy and Hypertens,1996,5:166.
  • 3[3]Dyer AR,Elliott P,Shipley M.Intersalt cooperative rasearch group:urinary electrolyte excriton in 24-hour and blood pressure in the intersalt study[J].Am J Epidemiol,1996,139:940.
  • 4[4]Weinberger MH. Salt sensitivity of blood pressure in humans[J].Hypertension,1996,27(2):481.
  • 5[5]Calhoun DA,Oparil S.Racial difference in the pathogenesis of hypertension[J]. Am J Sci,1995,310 (Suppl 1):86.
  • 6[6]Hashimoto J,Imai Y,Minami N,et al. A high-salt diet alters circadian blood pressure rhythm in Dahl rats [J].Tohoku J Exp Med,1994,173(3):345.
  • 7[7]Calhoun DA,Zhu ST,Chen YF, et al.Gender and dietary NaCl in spontaneously hypertensive and wistar-Kyoto rats[J].Hypertension,1995,26:2885.
  • 8[8]Cailar GD,Ribstein J,Dures JP,et al.Sodium and left venticular mass in untreated hypertensive and normotensive subjects[J].Am Physiol,1992,263(Heart Circphysiol 32):177.
  • 9[9]Gu JM,Anand V,Sek EW,et al.Sodium induces hypertrophy of cultured myocardial myoblasts and vascular smooth muscle cells[J].Hypertension,1998,31:1083.
  • 10[10]Nickenig G,strehlow K,Roeling J,et al.Salt induces vascular AT1 receptor overexpression in vitro and in vivo [J].Hypertension,1998,31:1272.

共引文献33

同被引文献8

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部